Literature DB >> 18325968

Commentary: Controversies in NICE guidance on irritable bowel syndrome.

Nicholas J Talley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18325968      PMCID： PMC2265329          DOI： 10.1136/bmj.39504.409329.AD

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Systematic review on the management of irritable bowel syndrome in North America.

Authors:  Lawrence J Brandt; David Bjorkman; M Brian Fennerty; G Richard Locke; Kevin Olden; Walter Peterson; Eamonn Quigley; Philip Schoenfeld; Marvin Schuster; Nicholas Talley
Journal:  Am J Gastroenterol       Date:  2002-11       Impact factor: 10.864

2.  Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome.

Authors:  W E Whitehead; O S Palsson; A D Feld; R L Levy; M VON Korff; M J Turner; D A Drossman
Journal:  Aliment Pharmacol Ther       Date:  2006-07-01       Impact factor: 8.171

3.  A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.

Authors:  J Tack; D Broekaert; B Fischler; L Van Oudenhove; A M Gevers; J Janssens
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

4.  Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care.

Authors:  D S Sanders; M J Carter; D P Hurlstone; A Pearce; A M Ward; M E McAlindon; A J Lobo
Journal:  Lancet       Date:  2001-11-03       Impact factor: 79.321

5.  Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia.

Authors:  J Hammer; G D Eslick; S C Howell; E Altiparmak; N J Talley
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  Bran and irritable bowel syndrome: time for reappraisal.

Authors:  C Y Francis; P J Whorwell
Journal:  Lancet       Date:  1994-07-02       Impact factor: 79.321

Review 7.  Colorectal cancer screening: scientific review.

Authors:  Judith M E Walsh; Jonathan P Terdiman
Journal:  JAMA       Date:  2003-03-12       Impact factor: 56.272
  7 in total
  2 in total

1.  Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS.

Authors:  Massimo Bellini; Cesare Tosetti; Francesco Rettura; Riccardo Morganti; Christian Lambiase; Gabrio Bassotti; Pierfrancesco Visaggi; Andrea Pancetti; Edoardo Benedetto; Nicola de Bortoli; Paolo Usai-Satta; Rudi De Bastiani
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

2.  The Impact of an Individual Educational Program on the Quality of Life and Severity of Symptoms of Patients with Irritable Bowel Syndrome.

Authors:  Regina Sierżantowicz; Jolanta Lewko; Grażyna Jurkowska
Journal:  Int J Environ Res Public Health       Date:  2020-06-13       Impact factor: 3.390
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.